Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.

Ms. Stella Vidzro, Adaklu District Environmental Officer, Friday stated that open defaecation was a challenge, a practice ...

President Donald Trump’s blunt-force use of tariffs has forged a rare bipartisan alliance among Kentucky’s top leaders — ...

A new analysis of earthquake rupture directivity provides essential insights for seismic hazard and risk assessments in urban ...

Severe storms are expected this afternoon and evening, with damaging winds as the primary concern, though hail and tornadoes are also possible, forecasters say. The National Weather Service predicts ...